New Partnership to Develop Tools to Defend Against Misuse of AI in Synthetic Biology Biosecurity February 16, 2024
BARDA Offers Preclinical Testing Assistance for Botulinum Neurotoxin Candidate Therapeutics Medical Countermeasures February 9, 2024
People Who Have Previously Had Zika Run Higher Risk of Dengue Landing Them in Hospital Infectious Diseases February 6, 2024
NIH Funds Continued Development of Maxim Bio’s At-Home Test for COVID and Flu Biodetection February 1, 2024
Study Shows Potential Benefits of Newer, Non-Egg-Based Flu Vaccines Medical Countermeasures January 31, 2024
DARPA Announces EQUIP-A-Pharma Program to Advance Agile Pharmaceutical Manufacturing Medical Countermeasures January 28, 2024
NIAID Funding Development of Biomarkers and Tools for Radiation Emergency Triage Medical Countermeasures January 25, 2024
Promising New ‘circRNA’ Vaccines Explored in CEPI-HMRI Collaboration Medical Countermeasures January 25, 2024
Novavax Updated Protein-Based COVID-19 Vaccine Authorized in the UK Medical Countermeasures January 24, 2024